B

Biotoxtech Co Ltd
KOSDAQ:086040

Watchlist Manager
Biotoxtech Co Ltd
KOSDAQ:086040
Watchlist
Price: 2 650 KRW -0.75% Market Closed
Market Cap: 42.3B KRW
Section:
 

Relative Value

The Relative Value of one Biotoxtech Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 2 650 KRW, Biotoxtech Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Biotoxtech Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

0.9
P/S
P/S
Price to Sales
0.9
vs History
95
vs Industry
79
Median 3Y
2.3
Median 5Y
2.8
Industry
4.3
More Details
46.4
P/E
P/E
Price to Earnings
46.4
vs History
19
vs Industry
18
Median 3Y
-8.2
Median 5Y
16.5
Industry
33.8
More Details
8.6
P/OCF
P/OCF
Price to OCF
8.6
vs History
42
vs Industry
Median 3Y
-6.8
Median 5Y
-5.6
Industry
20.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
32
Median 3Y
-6.3
Median 5Y
6.1
Industry
27.4
More Details
1
P/B
P/B
Price to Book Value
1
vs History
95
vs Industry
74
Median 3Y
1.6
Median 5Y
2.1
Industry
3
More Details
1.4
EV/S
EV/S
Enterprise Value to Sales
1.4
vs History
95
vs Industry
68
Median 3Y
2.9
Median 5Y
3.1
Industry
4.3
More Details
13.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.7
vs History
57
vs Industry
5
Median 3Y
16.8
Median 5Y
16.5
Industry
9.7
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
6
Median 3Y
-19.6
Median 5Y
-12
Industry
19.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
2
Median 3Y
-10.1
Median 5Y
-8
Industry
25.5
More Details
12.9
EV/OCF
EV/OCF
Enterprise Value to OCF
12.9
vs History
42
vs Industry
Median 3Y
-8.5
Median 5Y
-6.5
Industry
20.4
More Details
24.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
24.4
vs History
14
vs Industry
Median 3Y
-5.2
Median 5Y
-6.3
Industry
28.3
More Details
0.5
EV/IC
EV/IC
Enterprise Value to IC
0.5
vs History
95
vs Industry
82
Median 3Y
0.9
Median 5Y
1.2
Industry
2.5
More Details

Multiples Across Competitors

Competitors Multiples
Biotoxtech Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Biotoxtech Co Ltd
KOSDAQ:086040
40.8B KRW 0.9 46.4 -33.3 -10
US
PerkinElmer Inc
LSE:0KHE
1.3T USD 446.5 5 290 1 551.2 3 116.4
US
Thermo Fisher Scientific Inc
NYSE:TMO
237.1B USD 5.4 36.1 25.5 33
US
Danaher Corp
NYSE:DHR
169B USD 7 48.2 25.8 39
CH
Lonza Group AG
SIX:LONN
38.5B CHF 5.4 52.5 39.9 39.9
CN
WuXi AppTec Co Ltd
SSE:603259
298.3B CNY 6.7 19.9 20.2 20.2
US
IQVIA Holdings Inc
NYSE:IQV
40.8B USD 2.6 31.8 15.3 22.9
US
Agilent Technologies Inc
NYSE:A
40.8B USD 5.9 31.3 24.2 28.8
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW 8.4 29 16.9 22.5
US
Mettler-Toledo International Inc
NYSE:MTD
30.2B USD 7.7 36.2 26 28.9
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.9B EUR 7.1 78.9 28 46
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
B
Biotoxtech Co Ltd
KOSDAQ:086040
Average EV/EBITDA: 177.3
Negative Multiple: -33.3 		N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 551.2
5%
310.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
25.5
6%
4.3
US
Danaher Corp
NYSE:DHR
25.8
5%
5.2
CH
Lonza Group AG
SIX:LONN
39.9
18%
2.2
CN
WuXi AppTec Co Ltd
SSE:603259
20.2
30%
0.7
US
IQVIA Holdings Inc
NYSE:IQV
15.3
8%
1.9
US
Agilent Technologies Inc
NYSE:A
24.2
13%
1.9
KR
Samsung Biologics Co Ltd
KRX:207940
16.9
20%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
26
4%
6.5
FR
Sartorius Stedim Biotech SA
PAR:DIM
28
19%
1.5

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 310,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.